Read all news items about the AGE Reader and Diagnoptics.
Groningen, the Netherlands – November 23, 2012.
At the recent so-called DDG Herbstagung dr. Kaltheuner gave a very interesting presentation about the daily clinical use of the AGE Reader.
Dr. Kaltheuner presented about his experiences with the AGE Reader in estimating cardiovascular risk in his diabetes patients. In his presentation dr. Kaltheuner stated that the current risk scores to estimate the cardiovascular risk of diabetics are far from perfect. An alternative measurement of cardiovascular risk would be very helpful, to decide whether or not to intensify treatment.
His conclusion was that the AGE Reader is a very easy method to use in daily practice that can be of added value in determining the cardiovascular risk of diabetes patients.
Link: http://www.herbsttagung-ddg.de/programm/freitag.html?getsinglehtml=21&druck=show
Would you like to learn more about our products? Request any information you wish to receive here.
If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.
More information about Diagnoptics.
Information on Diagnoptics' products and Advanced Glycation Endproducts.
Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.